Cannabis

Cannabis use may double risk of death from cardiovascular disease

A new study has found that cannabis use is linked to a doubling in the risk of dying from cardiovascular disease.

Can CBD help aid mental health issues?

CBD has been gaining popularity over recent years, with a wide range of CBD infused products available to buy on the high street, but what is it, and can it really help?.

MariPharm: The world’s first medicinal cannabis company

Here, General Manager Bart den Hertog, introduces MariPharm, the world’s first medicinal cannabis business, highlighting the company’s major milestone moments, its clinical trial process and recommended product dosage.

Organic hemp producer BioBloom: “Health is our main focus”

BioBloom has specialised in the production of high-quality organic hemp products with absolutely no additives since 2016. The production focuses on the preservation of all valuable ingredients of the hemp plant.

The Academy of Medical Cannabis

Professor Mike Barnes, Director of Education at The Academy of Medical Cannabis shares his thoughts on the rescheduling of cannabis to a Schedule II substance in November of 2018 and access to medical cannabis prescriptions.

The impact of cannabidiol on mainstream fast-moving consumer goods

Canna CBD Limited chart the impact of cannabidiol on mainstream fast-moving consumer goods, adopting custom from other lifestyle categories, such as alcohol, tobacco/vaping, cosmetics and health foods.

Medical marijuana: Developments in the industry

Ian C Tordoff, CEO of Block Commodities Ltd, provides a snap-shot of changes in the medical marijuana industry.

Industrial hemp: Part of the cannabis sativa family

Henri Sant-Cassia from CBD Virtue turns the spotlight onto industrial hemp, a part of the cannabis sativa family.

Regulation and quality control for the medical cannabis industry

AlphaCAT (Cannabinoid Analysis Test) takes the first step to regulation and quality control for the medical cannabis industry, as this profile by the firm’s Sebastien Beguerie sheds light on.

Is there a difference between Sativa and Indica cannabis?

Cannabis patient, budtender and growers assistant, Caleb McMillan, ponders if there is a difference between Sativa and Indica cannabis.

Europe setting standards for cannabis products

As government authorities come to grips with legislation of cannabis-based products, the European market holds a key position, Liam McGreevy, CEO, Ethnopharm Ltd explains.

Cannabis products: Greater diversity, increased potency and close monitoring

A recent European Monitoring Centre for Drugs and Drug Addiction report highlights the need for diversity of cannabis products, increased potency and close monitoring of health effects.

Can CBD kick your Seasonal Affective Disorder?

Simon Manthorpe, CEO of EOS Scientific, explains why CBD oil could be the answer for a calming solution to Seasonal Affective Disorder.

The cannabis industry in the UK: Risky business?

Is the cannabis industry in the UK a risky business? John Binns, Partner at BCL Solicitors LLP finds out more.

CBD: A brief introduction to a brand-new industry

Mile High Labs International Limited provides a brief introduction to a brand-new industry, CBD, a non-psychoactive cannabinoid.

Fundación CANNA: Promoting research, scientific studies and cannabis analysis

Here, we find out about Fundación CANNA’s aim is to promote research and education about cannabis, including their strong focus on the effects of this on the human body.

UK and Ireland medical cannabis access programmes and education slowly progress

GreenLight Pharmaceuticals Ltd is advancing clinical research and education in UK and Ireland; Though government progress on access and prescribing recommendations lags behind much of Europe.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders